| 6.4 |
19.2 |
GO:0046959 |
habituation(GO:0046959) |
| 4.8 |
14.3 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 3.7 |
11.2 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 3.7 |
11.1 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 3.6 |
10.9 |
GO:0072194 |
kidney smooth muscle tissue development(GO:0072194) |
| 3.2 |
9.6 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 3.1 |
6.3 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 3.1 |
40.3 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 3.1 |
18.4 |
GO:0021636 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
| 2.9 |
11.6 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 2.9 |
8.6 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
| 2.8 |
11.0 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 2.7 |
8.1 |
GO:0060023 |
soft palate development(GO:0060023) |
| 2.7 |
10.7 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 2.7 |
8.0 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 2.5 |
2.5 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 2.4 |
9.5 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 2.3 |
18.5 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 2.3 |
4.6 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 2.3 |
9.2 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 2.3 |
6.9 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 2.3 |
6.8 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 2.3 |
6.8 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 2.2 |
13.2 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 2.2 |
8.7 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 2.2 |
6.5 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 2.1 |
6.4 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 2.1 |
2.1 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 2.1 |
8.3 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 2.0 |
5.9 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 1.9 |
38.3 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 1.9 |
24.3 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 1.9 |
20.4 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 1.8 |
5.5 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.8 |
5.5 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 1.8 |
7.0 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 1.8 |
5.3 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 1.7 |
8.7 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 1.7 |
7.0 |
GO:0086042 |
cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 1.7 |
6.8 |
GO:0021586 |
pons maturation(GO:0021586) |
| 1.7 |
5.1 |
GO:1904059 |
positive regulation of sensory perception of pain(GO:1904058) regulation of locomotor rhythm(GO:1904059) |
| 1.7 |
1.7 |
GO:1904173 |
regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
| 1.7 |
10.1 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 1.7 |
10.0 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 1.7 |
5.0 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.6 |
6.6 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.6 |
1.6 |
GO:0050883 |
musculoskeletal movement, spinal reflex action(GO:0050883) |
| 1.6 |
8.0 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 1.6 |
1.6 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 1.5 |
4.5 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 1.5 |
4.5 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 1.5 |
10.6 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 1.5 |
7.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 1.5 |
4.5 |
GO:0003289 |
septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
| 1.5 |
1.5 |
GO:0042596 |
fear response(GO:0042596) |
| 1.5 |
13.4 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) |
| 1.5 |
3.0 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 1.5 |
1.5 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 1.5 |
4.4 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 1.4 |
32.9 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 1.4 |
5.7 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 1.4 |
7.1 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 1.4 |
9.9 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 1.4 |
9.7 |
GO:0097324 |
melanocyte migration(GO:0097324) |
| 1.4 |
19.3 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 1.3 |
8.0 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 1.3 |
4.0 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 1.3 |
5.2 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 1.3 |
3.9 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 1.3 |
7.7 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 1.3 |
5.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.2 |
3.7 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
| 1.2 |
3.7 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 1.2 |
1.2 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 1.2 |
1.2 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 1.2 |
13.9 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 1.2 |
4.6 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 1.2 |
5.8 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 1.1 |
5.7 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 1.1 |
4.6 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 1.1 |
13.4 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.1 |
10.0 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 1.1 |
2.2 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 1.1 |
3.3 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 1.1 |
4.4 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 1.1 |
1.1 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 1.1 |
5.3 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 1.1 |
3.2 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 1.1 |
2.1 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 1.0 |
3.1 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 1.0 |
3.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 1.0 |
7.2 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 1.0 |
3.1 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 1.0 |
1.0 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 1.0 |
15.2 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 1.0 |
4.0 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 1.0 |
3.0 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 1.0 |
4.0 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.0 |
28.3 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 1.0 |
2.9 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 1.0 |
7.7 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 1.0 |
3.9 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 1.0 |
3.8 |
GO:0072186 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 1.0 |
7.6 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.9 |
1.9 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.9 |
6.6 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.9 |
4.6 |
GO:1902669 |
positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
| 0.9 |
2.7 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.9 |
11.9 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.9 |
3.6 |
GO:0032429 |
regulation of phospholipase A2 activity(GO:0032429) |
| 0.9 |
4.6 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.9 |
4.5 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.9 |
10.8 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.9 |
2.7 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 0.9 |
2.7 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.9 |
2.7 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.9 |
1.8 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) ganglion morphogenesis(GO:0061552) facioacoustic ganglion development(GO:1903375) dorsal root ganglion morphogenesis(GO:1904835) |
| 0.9 |
16.7 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.9 |
15.8 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.9 |
3.5 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.9 |
4.3 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.9 |
6.9 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.9 |
4.3 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.9 |
1.7 |
GO:1903243 |
regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.8 |
3.4 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
| 0.8 |
5.9 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.8 |
5.0 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.8 |
4.1 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.8 |
3.3 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.8 |
2.5 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.8 |
2.5 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.8 |
12.3 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.8 |
2.5 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.8 |
8.9 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.8 |
13.0 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.8 |
2.4 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.8 |
4.0 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.8 |
3.2 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.8 |
8.8 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.8 |
20.7 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 0.8 |
4.0 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.8 |
1.6 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.8 |
2.3 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.8 |
2.3 |
GO:1904417 |
regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.8 |
5.4 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.8 |
1.5 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.8 |
5.3 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.8 |
3.0 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.8 |
3.8 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.8 |
21.2 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.7 |
2.2 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.7 |
2.2 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.7 |
2.2 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.7 |
2.2 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.7 |
3.7 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.7 |
5.1 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.7 |
1.4 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.7 |
1.4 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.7 |
11.9 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.7 |
1.4 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.7 |
0.7 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.7 |
2.1 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.7 |
2.0 |
GO:0044337 |
canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
| 0.7 |
3.4 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.7 |
2.7 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.7 |
4.0 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.7 |
7.4 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.7 |
2.0 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.7 |
1.3 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.7 |
2.0 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.6 |
18.2 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.6 |
1.9 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.6 |
3.8 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.6 |
2.6 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 0.6 |
22.6 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.6 |
0.6 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 0.6 |
1.9 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 0.6 |
1.8 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.6 |
1.2 |
GO:1901881 |
positive regulation of protein depolymerization(GO:1901881) |
| 0.6 |
5.5 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.6 |
2.4 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.6 |
1.8 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.6 |
3.6 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.6 |
2.4 |
GO:2000822 |
regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
| 0.6 |
6.0 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.6 |
17.8 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.6 |
1.2 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.6 |
5.3 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.6 |
4.1 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.6 |
1.2 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.6 |
1.2 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.6 |
1.2 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.6 |
1.7 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.6 |
2.3 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.6 |
1.7 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.6 |
1.1 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.6 |
1.7 |
GO:0014848 |
urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.6 |
2.3 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.6 |
1.7 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.6 |
2.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.6 |
0.6 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.6 |
2.2 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.6 |
2.8 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.6 |
1.7 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.6 |
4.4 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.6 |
3.9 |
GO:0045820 |
negative regulation of glycolytic process(GO:0045820) |
| 0.6 |
1.7 |
GO:0001907 |
killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.5 |
2.2 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.5 |
1.6 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
| 0.5 |
6.0 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.5 |
2.2 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.5 |
2.7 |
GO:0042635 |
positive regulation of hair cycle(GO:0042635) |
| 0.5 |
6.5 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.5 |
3.7 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.5 |
1.6 |
GO:1903423 |
positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.5 |
1.6 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.5 |
6.9 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.5 |
1.1 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.5 |
3.2 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.5 |
2.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.5 |
2.6 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.5 |
1.6 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.5 |
1.6 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.5 |
1.6 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.5 |
17.1 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.5 |
3.6 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.5 |
12.4 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.5 |
7.7 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) |
| 0.5 |
3.1 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.5 |
2.1 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.5 |
3.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.5 |
2.5 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.5 |
5.6 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.5 |
0.5 |
GO:0034727 |
lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
| 0.5 |
2.5 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.5 |
0.5 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.5 |
3.0 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.5 |
1.0 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.5 |
0.5 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.5 |
1.5 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.5 |
1.5 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.5 |
1.5 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.5 |
6.8 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.5 |
1.0 |
GO:0048341 |
paraxial mesoderm formation(GO:0048341) |
| 0.5 |
5.8 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.5 |
2.9 |
GO:0035729 |
response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.5 |
4.3 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.5 |
1.4 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.5 |
1.4 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.5 |
7.1 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.5 |
3.3 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.5 |
4.6 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.5 |
1.9 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.5 |
1.8 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.5 |
0.9 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.5 |
3.2 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.5 |
0.5 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.4 |
2.7 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.4 |
3.6 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.4 |
0.9 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.4 |
5.8 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.4 |
4.0 |
GO:0071824 |
protein-DNA complex assembly(GO:0065004) protein-DNA complex subunit organization(GO:0071824) |
| 0.4 |
2.6 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.4 |
0.9 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 0.4 |
1.3 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.4 |
1.7 |
GO:0070244 |
negative regulation of thymocyte apoptotic process(GO:0070244) |
| 0.4 |
6.4 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.4 |
0.4 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.4 |
3.4 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.4 |
1.3 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.4 |
1.3 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.4 |
2.1 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.4 |
5.5 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.4 |
1.7 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.4 |
1.7 |
GO:0097393 |
post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) |
| 0.4 |
1.3 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.4 |
0.8 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.4 |
1.2 |
GO:0032910 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.4 |
1.7 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.4 |
1.2 |
GO:0060010 |
positive regulation of type 2 immune response(GO:0002830) positive regulation of T-helper 2 cell differentiation(GO:0045630) Sertoli cell fate commitment(GO:0060010) |
| 0.4 |
8.6 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.4 |
4.9 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.4 |
1.2 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.4 |
4.0 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.4 |
2.0 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.4 |
1.6 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.4 |
2.0 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.4 |
0.4 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.4 |
1.2 |
GO:0086013 |
membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
| 0.4 |
1.2 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.4 |
4.7 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.4 |
0.8 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) purine nucleobase salvage(GO:0043096) hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.4 |
1.2 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 0.4 |
1.9 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.4 |
4.2 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.4 |
2.3 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.4 |
1.9 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.4 |
1.5 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.4 |
0.8 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.4 |
1.1 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.4 |
5.2 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.4 |
3.0 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.4 |
1.8 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.4 |
1.1 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.4 |
1.8 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.4 |
2.6 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.4 |
2.5 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.4 |
0.7 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.4 |
1.1 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.4 |
2.2 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.4 |
1.1 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.4 |
1.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.4 |
4.2 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.4 |
0.7 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.4 |
5.6 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.4 |
2.5 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.3 |
2.8 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.3 |
0.3 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.3 |
4.1 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.3 |
3.1 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.3 |
5.1 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.3 |
3.4 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.3 |
4.8 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.3 |
0.7 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.3 |
2.4 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.3 |
0.7 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.3 |
3.7 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.3 |
1.3 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.3 |
2.0 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.3 |
0.3 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.3 |
1.3 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.3 |
3.0 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.3 |
1.6 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.3 |
1.0 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.3 |
8.0 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.3 |
3.5 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.3 |
0.6 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.3 |
2.2 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.3 |
1.2 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.3 |
6.5 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.3 |
1.8 |
GO:0042297 |
vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
| 0.3 |
0.9 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.3 |
0.9 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.3 |
1.8 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.3 |
9.8 |
GO:0061001 |
regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.3 |
1.2 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.3 |
1.8 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.3 |
0.3 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 0.3 |
1.8 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.3 |
2.4 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.3 |
3.8 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.3 |
0.9 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.3 |
0.6 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.3 |
2.3 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.3 |
1.5 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.3 |
2.3 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.3 |
2.6 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.3 |
0.6 |
GO:0042761 |
very long-chain fatty acid biosynthetic process(GO:0042761) |
| 0.3 |
1.1 |
GO:0072592 |
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) oxygen metabolic process(GO:0072592) |
| 0.3 |
0.3 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.3 |
0.6 |
GO:0051712 |
positive regulation of killing of cells of other organism(GO:0051712) |
| 0.3 |
1.7 |
GO:0090129 |
positive regulation of synapse maturation(GO:0090129) |
| 0.3 |
1.7 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.3 |
0.3 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.3 |
3.7 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.3 |
1.1 |
GO:0021932 |
hindbrain radial glia guided cell migration(GO:0021932) |
| 0.3 |
1.1 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.3 |
0.8 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) response to methylglyoxal(GO:0051595) regulation of histone H3-K27 acetylation(GO:1901674) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.3 |
4.7 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.3 |
1.4 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.3 |
0.6 |
GO:0048261 |
negative regulation of receptor-mediated endocytosis(GO:0048261) |
| 0.3 |
2.5 |
GO:0046831 |
regulation of RNA export from nucleus(GO:0046831) |
| 0.3 |
3.0 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.3 |
0.3 |
GO:0031958 |
corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.3 |
0.3 |
GO:1903430 |
negative regulation of neuron maturation(GO:0014043) negative regulation of cell maturation(GO:1903430) |
| 0.3 |
1.9 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.3 |
1.1 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.3 |
1.4 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.3 |
4.3 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.3 |
1.3 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.3 |
0.5 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.3 |
1.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 |
1.1 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.3 |
1.1 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
| 0.3 |
0.5 |
GO:0035793 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 0.3 |
5.8 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.3 |
0.8 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
| 0.3 |
0.5 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.3 |
1.3 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.3 |
1.0 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.3 |
0.5 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.3 |
1.5 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.3 |
2.0 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.3 |
1.0 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.3 |
1.8 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.3 |
0.3 |
GO:0046016 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.3 |
2.5 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.2 |
1.0 |
GO:0060709 |
glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
| 0.2 |
1.0 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.2 |
1.7 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.2 |
3.7 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.2 |
0.7 |
GO:0060368 |
regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.2 |
1.0 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.2 |
6.3 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.2 |
3.1 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.2 |
1.2 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.2 |
2.1 |
GO:0010586 |
miRNA metabolic process(GO:0010586) |
| 0.2 |
0.9 |
GO:0044532 |
modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation by symbiont of host apoptotic process(GO:0052150) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.2 |
2.3 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.2 |
1.2 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.2 |
1.6 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.2 |
2.5 |
GO:0098910 |
regulation of atrial cardiac muscle cell action potential(GO:0098910) |
| 0.2 |
0.7 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.2 |
1.8 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.2 |
0.7 |
GO:1902219 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.2 |
0.2 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.2 |
4.6 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.2 |
2.6 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 |
1.1 |
GO:0072367 |
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.2 |
0.7 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.2 |
0.7 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.2 |
0.7 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.2 |
0.4 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.2 |
0.9 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.2 |
0.6 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.2 |
1.3 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 0.2 |
0.9 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.2 |
1.1 |
GO:0032811 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) regulation of epinephrine secretion(GO:0014060) negative regulation of epinephrine secretion(GO:0032811) epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
| 0.2 |
1.5 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.2 |
1.1 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 |
3.2 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.2 |
2.5 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.2 |
0.6 |
GO:2000650 |
negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
| 0.2 |
2.5 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.2 |
1.2 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.2 |
0.4 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.2 |
3.9 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.2 |
1.2 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.2 |
1.0 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.2 |
2.3 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.2 |
1.4 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.2 |
1.2 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.2 |
0.6 |
GO:0033700 |
phospholipid efflux(GO:0033700) |
| 0.2 |
1.2 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.2 |
0.6 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.2 |
0.8 |
GO:0034661 |
ncRNA catabolic process(GO:0034661) |
| 0.2 |
0.4 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.2 |
1.8 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.2 |
1.2 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.2 |
1.8 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.2 |
1.0 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.2 |
7.9 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.2 |
2.2 |
GO:0097352 |
autophagosome maturation(GO:0097352) |
| 0.2 |
0.8 |
GO:0001759 |
organ induction(GO:0001759) |
| 0.2 |
3.9 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.2 |
1.0 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.2 |
1.0 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.2 |
1.4 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.2 |
1.2 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.2 |
1.7 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.2 |
5.4 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.2 |
0.4 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.2 |
0.2 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 |
1.0 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.2 |
0.8 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.2 |
1.9 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.2 |
0.8 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.2 |
11.9 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.2 |
0.2 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.2 |
3.0 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.2 |
0.6 |
GO:0048686 |
axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.2 |
2.2 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.2 |
0.9 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.2 |
6.2 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.2 |
6.0 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.2 |
1.1 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.2 |
5.4 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.2 |
2.5 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.2 |
0.7 |
GO:0099565 |
regulation of postsynaptic membrane potential(GO:0060078) chemical synaptic transmission, postsynaptic(GO:0099565) |
| 0.2 |
0.5 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.2 |
1.9 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.2 |
2.1 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.2 |
2.0 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.2 |
0.7 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.2 |
2.4 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.2 |
1.9 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.2 |
1.3 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.2 |
0.8 |
GO:0023021 |
termination of signal transduction(GO:0023021) termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.2 |
0.5 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.2 |
3.6 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.2 |
0.7 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 |
3.4 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.2 |
3.1 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.2 |
0.5 |
GO:0007128 |
meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
| 0.2 |
1.1 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.2 |
9.1 |
GO:0071806 |
intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 0.2 |
0.2 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.2 |
0.5 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.2 |
0.5 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.2 |
0.8 |
GO:0019086 |
late viral transcription(GO:0019086) |
| 0.2 |
1.7 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.2 |
0.9 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 |
1.2 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
3.0 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.4 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.1 |
0.3 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.1 |
1.3 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.1 |
1.0 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
1.7 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.1 |
1.0 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.6 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 |
0.4 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.1 |
6.6 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.1 |
1.0 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.1 |
0.6 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
0.6 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) cytosol to ER transport(GO:0046967) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
0.4 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.4 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.1 |
0.6 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.1 |
8.0 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.1 |
1.8 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
1.6 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) |
| 0.1 |
3.7 |
GO:0048814 |
regulation of dendrite morphogenesis(GO:0048814) |
| 0.1 |
10.0 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
| 0.1 |
0.5 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.9 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
1.4 |
GO:0040020 |
regulation of meiotic nuclear division(GO:0040020) |
| 0.1 |
0.7 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.1 |
0.5 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.1 |
0.1 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.1 |
0.8 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.1 |
0.3 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.1 |
0.5 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
1.1 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.1 |
1.5 |
GO:1901216 |
positive regulation of neuron death(GO:1901216) |
| 0.1 |
1.8 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
0.6 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
16.8 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 |
1.1 |
GO:0002335 |
mature B cell differentiation(GO:0002335) |
| 0.1 |
0.6 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
2.3 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
1.5 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.4 |
GO:0014866 |
skeletal myofibril assembly(GO:0014866) |
| 0.1 |
0.8 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.3 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
0.2 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.8 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.1 |
0.1 |
GO:0003419 |
growth plate cartilage chondrocyte proliferation(GO:0003419) regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.1 |
0.5 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.1 |
0.5 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 |
0.1 |
GO:0060353 |
cell adhesion molecule production(GO:0060352) regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.1 |
0.5 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
1.7 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.1 |
1.1 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 |
8.6 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.1 |
0.6 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
0.4 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.1 |
0.8 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.1 |
0.2 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.1 |
2.0 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.1 |
3.4 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.7 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.1 |
0.3 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.1 |
2.2 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.1 |
0.1 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.1 |
0.4 |
GO:0051447 |
negative regulation of meiotic cell cycle(GO:0051447) |
| 0.1 |
0.8 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 |
0.8 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 |
0.9 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.1 |
0.6 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 |
1.3 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
0.2 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.1 |
0.4 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.1 |
0.2 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.1 |
0.5 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.7 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.1 |
0.8 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
5.2 |
GO:0035304 |
regulation of protein dephosphorylation(GO:0035304) |
| 0.1 |
0.9 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.1 |
0.1 |
GO:1900744 |
regulation of p38MAPK cascade(GO:1900744) |
| 0.1 |
0.9 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
0.4 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.1 |
1.3 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.5 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 |
0.4 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.1 |
3.3 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.1 |
1.4 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
0.6 |
GO:0010830 |
regulation of myotube differentiation(GO:0010830) |
| 0.1 |
0.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
1.5 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.4 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
1.9 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.1 |
0.3 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.1 |
0.2 |
GO:0010762 |
regulation of fibroblast migration(GO:0010762) |
| 0.1 |
0.9 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.1 |
0.5 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.5 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.1 |
0.2 |
GO:0060982 |
coronary artery morphogenesis(GO:0060982) |
| 0.1 |
0.4 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.1 |
0.8 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
0.4 |
GO:1901796 |
regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.1 |
4.6 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.1 |
0.3 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 |
0.8 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.1 |
0.3 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.1 |
0.2 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
9.3 |
GO:0007018 |
microtubule-based movement(GO:0007018) |
| 0.1 |
0.3 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 |
0.6 |
GO:0051647 |
nucleus localization(GO:0051647) |
| 0.1 |
0.8 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
1.2 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.3 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.1 |
1.5 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.1 |
0.3 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.1 |
0.5 |
GO:0016445 |
somatic diversification of immunoglobulins(GO:0016445) |
| 0.1 |
0.1 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.1 |
0.3 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.1 |
2.0 |
GO:0097202 |
activation of cysteine-type endopeptidase activity(GO:0097202) |
| 0.1 |
1.0 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 |
1.1 |
GO:0048002 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) antigen processing and presentation of peptide antigen(GO:0048002) |
| 0.1 |
0.2 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.1 |
0.4 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
0.9 |
GO:0044243 |
collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.1 |
0.5 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.1 |
0.6 |
GO:0048505 |
regulation of timing of cell differentiation(GO:0048505) |
| 0.1 |
0.9 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.2 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 |
0.7 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.1 |
0.2 |
GO:0071476 |
hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
| 0.1 |
0.4 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
0.4 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.1 |
0.1 |
GO:0003014 |
renal system process(GO:0003014) |
| 0.1 |
0.2 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
0.4 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
0.3 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 |
0.1 |
GO:2000811 |
regulation of anoikis(GO:2000209) negative regulation of anoikis(GO:2000811) |
| 0.1 |
0.6 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 |
0.3 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.1 |
0.5 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.1 |
0.3 |
GO:0051875 |
melanosome localization(GO:0032400) pigment granule localization(GO:0051875) |
| 0.1 |
1.5 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 |
0.3 |
GO:0090179 |
planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.1 |
0.2 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.1 |
1.1 |
GO:0006406 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.1 |
0.2 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.1 |
0.1 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.1 |
0.7 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.2 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.0 |
0.1 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.0 |
0.1 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.0 |
0.1 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.0 |
1.8 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.0 |
0.1 |
GO:0044320 |
leptin-mediated signaling pathway(GO:0033210) cellular response to leptin stimulus(GO:0044320) |
| 0.0 |
0.3 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 |
0.1 |
GO:0021756 |
striatum development(GO:0021756) |
| 0.0 |
0.7 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.7 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.0 |
0.1 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.0 |
0.1 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.0 |
0.4 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.5 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.0 |
2.8 |
GO:0046488 |
phosphatidylinositol metabolic process(GO:0046488) |
| 0.0 |
0.2 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 0.0 |
0.1 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.0 |
1.2 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.1 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.0 |
0.4 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 |
0.4 |
GO:0051974 |
negative regulation of telomerase activity(GO:0051974) |
| 0.0 |
0.6 |
GO:0031103 |
axon regeneration(GO:0031103) |
| 0.0 |
0.2 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.0 |
0.5 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
0.0 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.0 |
0.2 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.0 |
0.8 |
GO:0072337 |
modified amino acid transport(GO:0072337) |
| 0.0 |
0.2 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.0 |
0.3 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.0 |
0.3 |
GO:0009048 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.0 |
0.5 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.0 |
0.1 |
GO:0016572 |
histone phosphorylation(GO:0016572) |
| 0.0 |
0.7 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.0 |
0.1 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.0 |
0.4 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 |
4.5 |
GO:0006470 |
protein dephosphorylation(GO:0006470) |
| 0.0 |
0.1 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.0 |
0.1 |
GO:0060768 |
regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
| 0.0 |
0.2 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.7 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 |
0.3 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 |
0.4 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
0.6 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.0 |
0.9 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.0 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.0 |
0.1 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.0 |
1.0 |
GO:0006497 |
protein lipidation(GO:0006497) |
| 0.0 |
0.2 |
GO:0048753 |
pigment granule organization(GO:0048753) |
| 0.0 |
0.1 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
0.3 |
GO:0006405 |
RNA export from nucleus(GO:0006405) |
| 0.0 |
0.2 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.0 |
0.3 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
1.2 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.2 |
GO:0010955 |
negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.0 |
0.1 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.0 |
0.2 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.0 |
0.1 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.0 |
0.2 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.0 |
0.2 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.0 |
0.1 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.0 |
0.2 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.1 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.0 |
0.2 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
0.3 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 |
0.2 |
GO:1902253 |
regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902253) |
| 0.0 |
0.3 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.1 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 |
0.2 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.0 |
0.1 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.0 |
0.0 |
GO:0001828 |
inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.0 |
0.1 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.0 |
0.2 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.0 |
0.1 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 |
0.1 |
GO:0006283 |
transcription-coupled nucleotide-excision repair(GO:0006283) |
